Hear testimonials from attendees of ChinaBio® Partnering Forum on how they increased their global business collaborations through the connections they made.

“This is a great time to have a lot of cross-border collaboration, whether you are a multinational company or a small biotech. When thinking about the second largest economy in the world, there are actually a lot of commercial opportunities to get your drug approved in China without the multi-year lag that people are currently experiencing.”

- Ji Li, Executive VP and Global Head of Business Development at BeiGene, speaking at BIO-Europe Spring® 2017 panel “Innovation in an uncertain world.”